Yang Wang
Greater China Region Guide 2024
Corporate/M&A: Mainland China-based (International Firms) + 1 more ranking
Email address
[email protected]Contact number
+86-10-5965-2976Share profile
Band 3
Band 3
About
Provided by Yang Wang
Practice Areas
Yang Wang is a Partner in the Beijing office of Simpson Thacher & Bartlett. He represents private equity funds and corporate clients on various mergers and acquisitions, private equity investments, corporate finance transactions and other general corporate matters. His recent transactions include advising Apax, Blackstone, Hillhouse, KKR, Macquarie, Primavera, Warburg Pincus and their respective portfolio companies in various leveraged buy-outs and private equity investments in Greater China of over US$20 billion in the aggregate, New Frontier Corporation in its US$1.3 billion acquisition of United Family Healthcare and the buyer consortium in the subsequent $1.6 billion privatization of United Family Healthcare, Xpeng in receiving approximately US$700 million minority investment by the Volkswagen Group and its Series C/C+ equity financing totaling more than US$1 billion, Ant Financial in its US$14 billion Series C equity financing, Alibaba in its US$4.3 billion investment in Suning, and ChemChina in its US$43 billion acquisition of Syngenta AG. He is fluent in Mandarin Chinese and English.
Career
Joined Simpson Thacher & Bartlett in 2010, Partner since 2018.
Personal
University of Michigan Law School (JD, magna cum laude, 2008); University of Maryland (B.S., magna cum laude, 2001; B.A., summa cum laude, 2000).
Professional Memberships
New York State Bar Association
Discover other Lawyers at
Simpson Thacher & Bartlett LLP
China
